4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-26-000302
Options or other derivatives
- Director acquired 5,860 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Scopa James Paul Director | 2026-06-25 | Grant or award · Stock Option (Right to Buy) | +5,860 | 5,860 | D: show line 1 in the form |
Loading xslF345X06/form4.xml…